Solstar Pharma is pleased to announce the appointment of Nahum Sonenberg, PhD to its Board of Scientific Advisors. In this role, Prof. Sonenberg will leverage his extensive experience in RNA and cancer research to help guide Solstar Pharma’s projects and overall R&D strategy.
“We are extremely proud to welcome Prof. Sonenberg to our Scientific Advisory Board. His many discoveries and contributions to biomedical research have significantly advanced medicine. Having someone of his stature is an incredible complement to our company. We look forward to drawing on Prof. Sonenberg’s extensive experience and knowledge as we continue to forge ahead with our plans to become a leader in the RNAi field.”— Tom Rossi, President and CEO of Solstar Pharma